0 seconds of 2 minutes, 17 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
02:17
02:17
 
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 closed down 0.38% at 7,969 points.

Energy was the best performing sector, up1%, followed by Staples, up 0.4%, and Materials, up 0.33%.

Real Estate was the biggest loser, down 2.2%, followed by IT, down 2%, and Discretionary, down 1%.

In the Green

Core Lithium (ASX:CXO) closed up 5.2% following the release of an update on its Finniss Lithium Operation.

Core Lithium closed at 8 cents.

Neuren Pharmaceuticals (ASX:NEU) finished up 0.67% on news the company is developing a new product to treat infant injuries when a baby’s brain does not receive enough oxygen or blood flow before or shortly after birth.

Neuren Pharmaceuticals finished at $12.01.

And, Reject Shop (ASX:TRS) has closed up 109% after investors flocked to the stock as the company received a takeover offer. Canada’s Dollarama (TSX:DOL) cut a deal to buy Reject Shop for $259 million.

Reject Shop closed at $6.60.

In the Red

Domain (ASX:DHG) closed down 4.9% after CoStar Group (NASDAQ:CSGP) improved its takeover offer, from $4.20 cash per share to $4.43 per share.

Domain wrapped up at $4.25.

Pro Medicus (ASX:PME) closed down 7.8% after being swept up in today’s tech sell-off. Broker Macquarie retained its “neutral” rating and its $257.40 price target.

Pro Medicus pulled up stumps at $210.00.

And, WiseTech (ASX:WTC) closed down 2% as investors reacted to Australian Super selling its entire $580M stake in the company.  AusSuper’s move came due to “governance concerns” and worries about the board.

Wisetech finished the day at $83.66.

More From The Market Online
Homes Australia

Domain gives CoStar month-long diligence period as market bets on deal ‘OK’

Domain Holdings (ASX:DHG) has given CoStar – the company offering to buy it at a 40%…
Image of drugs on a platform

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to…
Glass Bottles

Orora expects few troubles from French investigation into glass industry

Orora expects a slow-running French investigation into the glass packaging sector to pose few issues despite…
Pile of gold nuggets

Advance defining Happy Valley gold trend with maiden drilling at Myrtleford

Advance Metals Ltd has completed assays for its maiden diamond drill hole at the Happy Valley…